To evaluate the safety and efficacy of Cynatine HNS (hydrolyzed keratine peptidecapsule 250 mg)
- Conditions
- Health Condition 1: 3- Administration
- Registration Number
- CTRI/2020/01/023074
- Lead Sponsor
- Maxcure Nutravedics Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 0
1. All subjects willing to fill and sign ICFs [Informed Consent Forms]
2. Only females having age >= 25 to <= 65 years.
3. Females having clinical signs of stressed or damaged hairs.
4. Females with an agreement, not to use other possible cosmetic treatments which could interfere with the study.
5. Subject able to follow study procedures.
6. In generally good health.
7. Female, using birth control
8. Subjects who are able and are willing to comply with the protocol
9. Subjects ready to follow-up for entire duration of the study.
1. Subjects unwilling to sign on ICF
2. Any dermatological condition of the scalp other than hair loss and /or dandruff.
3. Any prior hair growth procedures (e.g., hair transplant or laser)
4. History of alcohol or drug addiction
5. History of skin allergy
6. Any active skin infection in the scalp area or scarring in the target area.
7. Subject had ever received radiation therapy to the scalp, or had chemotherapy within the past year.
8. Subject had participated in any investigational study within the 30 days prior to trial.
9. A history or the presence of any serious and/or chronic medical condition(s) including psychiatric illnesses] which, in the opinion of the investigator, may cause harm to the individual and/or compromise/confound the study results.
10. Subjects unwilling or unable to comply with the study procedures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method